Device manufacturer Stryker Corporation has reported a 13% decline in profits due to its recent Rejuvenate and ABG II hip replacement recalls. The voluntary Stryker recall has affected the company’s revenue to drop nearly $50 million in the first quarter.
Stryker could face several Rejuvenate and ABG II lawsuits after patients have complained of severe complications related to the hip devices. The Stryker recall took place in July 2012, two years after another popular metal-on-metal hip implant was recalled by a manufacturer.
Patients who have suffered from metal-on-metal hip replacement side effects have complained of limited mobility, corrosion and fretting, damaged tissue and metallosis, or toxic metal in the blood stream. Many patients have had to undergo revision surgery to fix hip implant problems.